BCR and B-cell chronic lymphocytic leukemia: We reasoned that, exploring the mechanism(s) in CLL B cells whereby BTKi regulates downstream gene expression would provide insights into the understanding of the pathobiological features of the BCR signaling pathway as well as new directions for CLL treatment.